The Cooper Companies, Inc. $COO Shares Bought by Vanguard Personalized Indexing Management LLC

Key Points

• Vanguard Personalized Indexing Management LLC increased its stake in The Cooper Companies by 19.6%, acquiring 3,751 additional shares during the second quarter, raising its total holding to 22,890 shares valued at approximately $1.63 million.
• Wall Street analysts have mixed ratings for Cooper Companies, with one Strong Buy, ten Buy, three Hold, and one Sell rating, and an average target price of $84.77.
• Cooper Companies announced a $2 billion stock buyback plan indicating the board's belief that the shares are currently undervalued, allowing for the repurchase of up to 15.4% of its stock.

Vanguard Personalized Indexing Management LLC raised its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 19.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,890 shares of the medical device company's stock after acquiring an additional 3,751 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in Cooper Companies were worth $1,629,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Sivik Global Healthcare LLC acquired a new stake in Cooper Companies in the second quarter valued at approximately $2,135,000. Apollon Wealth Management LLC raised its holdings in shares of Cooper Companies by 41.6% in the second quarter. Apollon Wealth Management LLC now owns 4,215 shares of the medical device company's stock worth $300,000 after buying an additional 1,238 shares during the last quarter. Aberdeen Group plc raised its holdings in shares of Cooper Companies by 11.0% in the second quarter. Aberdeen Group plc now owns 131,342 shares of the medical device company's stock worth $9,346,000 after buying an additional 13,011 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Cooper Companies by 24.7% in the second quarter. Blue Trust Inc. now owns 1,362 shares of the medical device company's stock worth $97,000 after buying an additional 270 shares during the last quarter. Finally, Triodos Investment Management BV raised its holdings in shares of Cooper Companies by 37.0% in the second quarter. Triodos Investment Management BV now owns 248,000 shares of the medical device company's stock worth $17,648,000 after buying an additional 67,000 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of research analyst reports. The Goldman Sachs Group set a $64.00 price target on shares of Cooper Companies and gave the stock a "sell" rating in a report on Wednesday, October 1st. Robert W. Baird decreased their price target on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a report on Thursday, August 28th. Mizuho decreased their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a report on Wednesday, July 16th. Needham & Company LLC reaffirmed a "buy" rating and issued a $94.00 price target on shares of Cooper Companies in a report on Thursday, August 28th. Finally, Wells Fargo & Company decreased their price target on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $84.77.

Cooper Companies Trading Up 0.6%

Shares of Cooper Companies stock opened at $71.97 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The firm has a fifty day moving average price of $69.51 and a 200 day moving average price of $73.28. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $109.04. The stock has a market cap of $14.31 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 1.88 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.06 billion. During the same quarter last year, the company posted $0.96 earnings per share. The firm's revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its board has approved a stock buyback plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to buy up to 15.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board believes its shares are undervalued.

Insider Activity at Cooper Companies

In other news, COO Daniel G. Mcbride purchased 3,000 shares of the company's stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the completion of the transaction, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Albert G. White III purchased 10,000 shares of the company's stock in a transaction that occurred on Friday, September 5th. The shares were purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the transaction, the chief executive officer owned 226,151 shares of the company's stock, valued at $15,466,466.89. This trade represents a 4.63% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 17,975 shares of company stock valued at $1,216,346 in the last quarter. 1.98% of the stock is currently owned by insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.